Literature DB >> 20877007

Location, location, regulation: a novel role for β-spectrin in the heart.

Kevin J Sampson1, Robert S Kass.   

Abstract

Voltage-gated Na(+) channels (VGSCs) are responsible for the rising phase of the action potential in excitable cells, including neurons and skeletal and cardiac myocytes. Small alterations in gating properties can lead to severe changes in cellular excitability, as evidenced by the plethora of heritable conditions attributed to mutations in VGSCs highlighting the need to better understand VGSC regulation. In this issue of the JCI, Hund et al. identify the ability of a key structural protein, β(IV)-spectrin, to bind and recruit Ca(2+)/calmodulin kinase II to the channel at a cellular location key to successful action potential initiation and propagation, where it can mediate function and excitability.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20877007      PMCID: PMC2947339          DOI: 10.1172/JCI44810

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  19 in total

Review 1.  Mechanism of local anesthetic drug action on voltage-gated sodium channels.

Authors:  H A Fozzard; P J Lee; G M Lipkind
Journal:  Curr Pharm Des       Date:  2005       Impact factor: 3.116

Review 2.  Regulation of the voltage-gated cardiac sodium channel Nav1.5 by interacting proteins.

Authors:  Hugues Abriel; Robert S Kass
Journal:  Trends Cardiovasc Med       Date:  2005-01       Impact factor: 6.677

3.  Inhibition of the late sodium current as a potential cardioprotective principle: effects of the late sodium current inhibitor ranolazine.

Authors:  L Belardinelli; J C Shryock; H Fraser
Journal:  Heart       Date:  2006-07       Impact factor: 5.994

4.  Ca2+/calmodulin-dependent protein kinase II regulates cardiac Na+ channels.

Authors:  Stefan Wagner; Nataliya Dybkova; Eva C L Rasenack; Claudius Jacobshagen; Larissa Fabritz; Paulus Kirchhof; Sebastian K G Maier; Tong Zhang; Gerd Hasenfuss; Joan Heller Brown; Donald M Bers; Lars S Maier
Journal:  J Clin Invest       Date:  2006-11-22       Impact factor: 14.808

Review 5.  Calcium, calmodulin, and calcium-calmodulin kinase II: heartbeat to heartbeat and beyond.

Authors:  Lars S Maier; Donald M Bers
Journal:  J Mol Cell Cardiol       Date:  2002-08       Impact factor: 5.000

Review 6.  Late sodium current is a new therapeutic target to improve contractility and rhythm in failing heart.

Authors:  Albertas Undrovinas; Victor A Maltsev
Journal:  Cardiovasc Hematol Agents Med Chem       Date:  2008-10

7.  Modulation of late sodium current by Ca2+, calmodulin, and CaMKII in normal and failing dog cardiomyocytes: similarities and differences.

Authors:  Victor A Maltsev; Vitaliy Reznikov; Nidas A Undrovinas; Hani N Sabbah; Albertas Undrovinas
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-01-18       Impact factor: 4.733

8.  Molecular basis of ranolazine block of LQT-3 mutant sodium channels: evidence for site of action.

Authors:  Sandra Fredj; Kevin J Sampson; Huajun Liu; Robert S Kass
Journal:  Br J Pharmacol       Date:  2006-05       Impact factor: 8.739

Review 9.  Inherited neuronal ion channelopathies: new windows on complex neurological diseases.

Authors:  William A Catterall; Sulayman Dib-Hajj; Miriam H Meisler; Daniela Pietrobon
Journal:  J Neurosci       Date:  2008-11-12       Impact factor: 6.167

Review 10.  Role of CaMKII for signaling and regulation in the heart.

Authors:  Lars S Maier
Journal:  Front Biosci (Landmark Ed)       Date:  2009-01-01
View more
  2 in total

1.  Expression of KCNA5 Protein in Human Mammary Epithelial Cell Line Associated with Caveolin-1.

Authors:  Jia Liu; Chao Qu; Hongyan Li; Yejun Zhang; Jia Sun; Shuo Yang; Jing Liu; Lijia An; Wei Zou
Journal:  J Membr Biol       Date:  2016-04-13       Impact factor: 1.843

2.  β2SP/TET2 complex regulates gene 5hmC modification after cerebral ischemia.

Authors:  Xiaohua Ma; Meng Zhang; Rui Yan; Hainan Wu; Bo Yang; Zhigang Miao
Journal:  J Cell Mol Med       Date:  2021-11-19       Impact factor: 5.310

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.